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From the genome analysis of the Mycobacterium tu-
berculosis two putative genes namely GlyA and GlyA2
have been proposed to encode for the enzyme serine
hydroxymethyltransferase. We have cloned, overex-
pressed, and purified to homogeneity their respective
protein products, serine hydroxymethyltransferase,
SHM1 and SHM2. The recombinant SHM1 and SHM2
exist as homodimers of molecular mass about 90 kDa
under physiological conditions, however, SHM2 has
more compact conformation and higher thermal stabil-
ity than SHM1. The most interesting structural observa-
tion was that the SHM1 contains 1 mol of pyridoxal
5-phosphate (PLP)/mol of enzyme dimer. This is the
first report of such a unique stoichiometry of PLP and
enzyme dimer for SHMT. The SHM2 contains 2 mol of
PLP/mol of enzyme dimer, which is the usual stoichiom-
etry reported for SHMT. Functionally both the recombi-
nant enzymes showed catalysis of reversible intercon-
version of serine and glycine and aldol cleavage of a
3-hydroxyamino acid. However, unlike SHMT from
other sources both SHM1 and SHM2 do not undergo
half-transamination reaction with D-alanine resulting in
formation of apoenzyme but L-cysteine removed the
prosthetic group, PLP, from both the recombinant en-
zymes leaving the respective inactive apoenzymes. Com-
parative structural studies on the two enzymes showed
that the SHM1 is resistant to alkaline denaturation up to
pH 10.5, whereas the native SHM2 dimer dissociates into
monomer at pH 9. Urea- and guanidinium chloride-in-
duced two-step unfolding of SHM1 and SHM2 with the
first step being dissociation of dimer into apomonomer
at low denaturant concentrations followed by unfolding
of the stabilized monomer at higher denaturant
concentrations.
Recent years have seen increased incidence of tuberculosis in
both developing and developed countries. Information avail-
able from the complete genome sequence of Mycobacterium
tuberculosis has the potential of providing the information that
would generate knowledge that will enable to elucidate the
unusual biology of its etiological agent, M. tuberculosis.
Serine hydroxymethyltransferase (SHMT),1 L-serine:tetra-
hydrofolate 5,10-hydroxymethyltransferase is a pyridoxyl 5-
phosphate (PLP)-dependent enzyme. SHMT reaction plays a
major role in cell physiology as it is considered to be a key
enzyme in the pathway for interconversion of folate coenzymes
that provide almost exclusively one-carbon fragments for the
biosynthesis of a variety of end products such as DNA, RNA,
ubiquinone, methionine, etc. (1–3). The physiological role of
SHMT is the reversible interconversion of serine to glycine and
irreversible hydrolysis of 5,10-CH-H4PteGlu to 5-CHO-
H4PteGlu. In addition to these physiological reactions, SHMT
also catalyzes, in the absence of H4PteGlu, the retroaldol cleav-
age of several 3-hydroxyamino acids, such as allo-threonine,
and the transamination and slow racemization of D- and L-
alanine (4, 5).
SHMT shows a ubiquitous distribution in nature, being
found both in the prokaryotes and eukaryotes. In eukaryotes,
SHMT exists as both cytosolic and mitochondrial isoforms (6)
encoded by the separate genes (7). A chloroplast isoform has
also been reported to be present in the plants (8) and Euglena
gracilis (9). Three molecular forms of SHMT have been de-
tected in choanomastigotes of Crithidia fasciculata. One of
them is cytosolic, whereas the other two forms are particle
bound, one being mitochondrial and the other one very likely is
glycosomal (10). A single form of SHMT has been detected in
epimastigotes of Trypanosoma cruzi (11).
Structurally SHMT from a mammalian source is a homotet-
ramer with a subunit molecular mass of about 53 kDa and
contains 4 mol of PLP/mol of enzyme (12, 13). The structural
details have revealed that the tetrameric enzyme is a dimer of
dimers (13). The three SHMT isoforms found in C. fasciculata
also have tetrameric structure (10). In contrast, the SHMT
from Escherichia coli as well as from several other bacterial
sources are dimeric and contain 2 mol of PLP/mol of enzyme
(14). Recently, it has been shown that the T. cruzi SHMT is
present as a catalytically active monomer (11). X-ray crystal
structure has shown that the coenzyme PLP is covalently at-
tached to the enzyme molecule and is located at the dimer
interface (12–14).
The folding/unfolding of both the tetrameric and the dimeric
SHMTs have been extensively studied (15–18). The tetrameric
SHMT undergoes a reversible unfolding with the first step
being dissociation of tetramer into dimer accompanied by the
removal of the enzyme-bound PLP from the active site (15).
Regarding the second step it was not clear whether the stabi-
lized dimer of SHMT unfolds directly or does so via the forma-
tion of monomer (15). For the dimeric SHMTs, both from E. coli
and Bacillus subtilis, the first step of unfolding is dissociation
of the native dimer into monomer followed by the unfolding of
* This work was supported by grants from the National Bioscience
Award for Career Development from the Department of Biotechnology,
New Delhi, and Indian Council of Medical Research Grant SSP150 (to
V. B.) and the Council of Scientific and Industrial Research, New Delhi
(to S. C.). The costs of publication of this article were defrayed in part
by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
‡ To whom correspondence should be addressed: Division of Molecu-
lar and Structural Biology, Central Drug Research Institute, Lucknow
226 001, India. Fax: 91-522-223405; E-mail: bhakuniv@rediffmail.com.
1 The abbreviations used are: SHMT, serine hydroxymethyltrans-
ferase; PLP, pyridoxal 5-phosphate; H4PteGlu, N
5-formyl-5,6,7,8-tet-
rahydropteroyl-L-glutamic acid; DTT, dithiothreitol; Tm, midpoint of
thermal denaturation; GdmCl, guanidinium chloride; PyP, pyridoxam-
ine-P; FRET, fluorescence resonance energy transfer.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 42, Issue of October 17, pp. 40793–40805, 2003
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 40793
 by guest, on August 11, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
the stabilized monomer (16–18). However, for the thermophilic
SHMT from Bacillus stearothermophilis, a highly cooperative
unfolding of the native dimer into unfolded monomer was re-
ported (18).
Searches of the M. tuberculosis genome for enzymes related
to SHMT have lead to the identification of two genes namely
the GlyA and GlyA2, which have been proposed as putative
genes encoding for SHMTs in the organism. Here we report the
cloning, overexpression, and purification of the recombinant
SHM1 and SHM2, the protein products of the genes GlyA and
GlyA2. Furthermore, the structural, functional, and stability
properties as well as the comparative studies on thermal, pH-,
urea-, and GdmCl- induced unfolding of both recombinant pro-
teins have been discussed in detail.
EXPERIMENTAL PROCEDURES
Cloning, Overexpression, and Purification of the Proteins of M. tuber-
culosis GlyA and GlyA2 Genes—The complete genes of M. tuberculosis
encoding functional GlyA and GlyA2 were amplified separately by PCR
from the genomic DNA. The different oligonucleotides used for GlyA,
based on the reported gene sequence (GenBankTM accession number
Rv1093), were upstream 5-GGAATTCCATATGTCTGCCCCGCTCGC-
TGAAGTT-3 and downstream 5-CCCAAGCTTGCGGCCGACCAGAC-
TCCACTC-3 for histidine-tagged protein and 5-CCCAAGCTTTTAG-
CGGCCGACCAGACTCCACTC-3 for non-histidine-tagged protein.
The different oligonucleotides for GlyA2 (GenBankTM accession number
Rv0070c) were upstream 5-GGAATTCCATATGAACACCCTCAACGA-
CTCCCTG-3 and downstream 5-ATAAGAATGCGGCCGCTGTACGA-
TGCAGTTCCGGGTA-3 for histidine-tagged protein and 5-CCCAAG-
CTTTTATGTACGATGCAGTTCCGTA-3 for non-histidine-tagged pro-
tein. Reactions were carried out in two phases for 5 and 30 cycles in a
total volume of 50 l with 2.5 units of Taq polymerase. For GlyA, the
first cycle without overhang amplification was 95 °C, 1 min; 54 °C, 1
min; 72 °C, 2 min; and the second cycle with overhang amplification
was 95 °C, 1 min; 60 °C, 1 min; 72 °C, 2 min with final extension for 10
min. For GlyA2, the first cycle without overhang amplification was
95 °C, 1 min; 44 °C, 1 min; 72 °C, 2 min, and the second cycle was
similar to the first cycle except for the annealing temperature of 56 °C
with final extension for 10 min. The amplified product was cloned into
pET-22b between the NdeI and HindIII sites. DNA sequencing con-
firmed the homogeneity of the sequences. The resultant constructs were
transformed into C41(DE3).
A single colony was inoculated into 10 ml of 2 YT broth having
ampicillin at a concentration of 100 g/ml and grown overnight at
30 °C. It was then subcultured in 1 liter of 2 YT media containing
similar ampicillin concentrations. For SHM1, the culture was induced
with 0.5 mM isopropyl-1-thio--D-galactopyranoside at A600 of 0.4 to 0.5
for 12 h at 30 °C, whereas SHM2 was grown for 18 h without any
induction. The cell culture was harvested followed by suspension into
50 mM potassium phosphate buffer, pH 7.8, containing 400 mM NaCl, 10
mM imidazole, 1 mM -mercaptoethanol, and 50 M PLP. Cells were
sonicated and centrifuged to remove the cell debris. The supernatant
was loaded on a nickel-nitrilotriacetic acid-agarose column pre-equili-
brated with the same buffer. To remove the nonspecific binding protein
constituents, the column was washed with 50 mM potassium phosphate
buffer, pH 7.4, containing 400 mM NaCl and 80 mM imidazole. The
protein was eluted with the same buffer containing 300 mM imidazole.
The fractions containing SHMT were pooled and glycerol and DTT were
added to final concentrations of 8% and 1 mM, respectively. Excess
imidazole was removed by dialysis against 25 mM potassium phosphate
buffer, pH 7.6, containing 50 mM NaCl, 1 mM EDTA, 8% glycerol, and 1
mM DTT. The purity of the purified proteins was checked by SDS-PAGE
(19) and ESI-MS and was found to be about 99% pure.
Circular Dichroism Measurements—The CD measurements were
made with a Jasco J810 spectropolarimeter calibrated with ammonium
()-10-camphorsulfonate and the results were expressed as relative
ellipticity and plotted as percentage values. The CD spectra were ob-
tained at enzyme concentrations of 2 and 10 M for far-UV CD and
visible CD measurements, respectively, with a 2-mm cell at 4 °C. The
values obtained were normalized by subtracting the baseline recorded
for the buffer having the same concentration of denaturant under
similar conditions.
Synthesis of PyP-SHMT—The reduction of the PLP aldimine was
achieved according to the procedure of Cai and Schirch (20).
Enzyme Activity—SHMT activity of the purified recombinant pro-
teins were determined as reported earlier (21, 22). Briefly, a 0.1-ml
reaction mixture contained 400 mM potassium phosphate buffer, pH
7.6, 1.8 mM DTT, 1 mM EDTA, 50 M PLP, 1.8 mM tetrahydrofolate, 3.6
mM L-[3-14C]serine, and approximately 1 M protein. After incubation at
37 °C for 20 min the reaction was stopped by the addition of 100 l of
dimedone (400 mM in 50% ethanol). The reaction mixture was kept in
boiling water bath for 5 min and the H-14CHO-dimedone adduct was
extracted into 3 ml of toluene. A 1-ml volume of toluene extract was
added to 5 ml of scintillation fluid (0.6% (w/v) 2,5-diphenyloxazole) and
the radioactivity was measured on the scintillation counter.
Activity was also measured by another reported method (23). A 1-ml
reaction mixture contained 1–70 g of enzyme, alcohol dehydrogenase
(100 g), NADH (250 M), 10 mM allo-threonine in 25 mM potassium
phosphate buffer, pH 7.6, 1 mM EDTA, and 1 mM DTT. The reference
cuvette contained all the chemicals except L-allo-threonine. The activity
was observed as decrease in the absorbance at 340 nm. The NADH
consumed in the reaction was calculated using a molar extinction coef-
ficient of 6220 M1 cm1.
Fluorescence Measurements—Fluorescence spectra were recorded
with PerkinElmer LS5B spectroluminesencemeter in a quartz cell with
a 5-mm path length. All samples were incubated for 6 h under specified
conditions before recording the spectra. For tryptophan fluorescence
measurements the excitation wavelength was 290 nm and the spectra
were recorded from 300 to 400 nm. The protein concentration used was
2 M and the measurement was carried out at 25 °C. For FRET studies
the samples were excited at 290 nm and the spectra were recorded from
300 to 450 nm.
Cross-linking Using Glutaraldehyde—To the native and urea- or
GdmCl-treated SHMT (1 M enzyme), an aliquot of 25% (w/v) glutar-
aldehyde was added to obtain a final glutaraldehyde concentration of
1%. The samples were incubated at 25 °C for 5 min followed by quench-
ing of the cross-linking reaction by the addition of 200 mM sodium
borohydride. After incubation for 20 min, 3 l of 10% aqueous sodium
deoxycholate was added. The pH of the reaction mixtures was lowered
to 2–2.5 by the addition of orthophosphoric acid, which resulted in
precipitation of the cross-linked proteins. After centrifugation
(13,000 g, 4 °C, 10 min) the obtained precipitates were re-dissolved in
0.1 M potassium phosphate buffer, pH 7.6, 1% SDS, and 50 mM DTT and
heated at 90–100 °C for 5 min. The molecular mass of the cross-linked
products was determined by 10% SDS-PAGE (19).
Size Exclusion Chromatography—The gel filtration experiments
were carried out on a Superdex 200HR 10/30 column (manufacturer’s
exclusion limit 600 kDa for proteins) on AKTA FPLC (Amersham Bio-
sciences). The columns were equilibrated and run on 25 mM potassium
phosphate buffer, pH 7.6, containing 1 mM EDTA, 100 mM NaCl, and 2
mM -mercaptoethanol (or mentioned otherwise) and the desired urea
or GdmCl concentration at 4 °C. The SHMT solution (10 M) was
incubated at the desired GdmCl or urea concentrations for 6 h at 4 °C.
These samples (200 l) were loaded on the column and run at 4 °C with
a flow rate of 0.3 ml/min.
pH-dependent Incubation—Recombinant SHM1 and SHM2 were dis-
solved in 10 mM citrate/glycine/Hepes buffer (pH of the solution main-
tained) of desired pH values and incubated for 4 h at 4 °C before making
the measurements.
Urea or Guanidinium Chloride Denaturation of SHMT—Recombi-
nant SHM1 and SHM2 (2 M) were dissolved in 25 mM potassium
phosphate buffer, pH 7.6, containing 1 mM EDTA, 50 mM NaCl, and 1
mM DTT in the presence and absence of increasing concentrations of
urea or GdmCl and incubated for 6 h at 4 °C. These samples were then
used for taking various measurements.
RESULTS AND DISCUSSION
Expression and Purification
The expression of both the SHM1 and SHM2 was good and
the expressed proteins were present predominantly (90%) in
the soluble fraction. The enzymes present in the soluble frac-
tion were purified by the method described under “Experimen-
tal Procedures.” The yield of both the enzymes was in the range
of 12 to 15 mg/liter. The purified proteins were homogenous as
indicated by a single protein band on SDS-PAGE (Fig. 1, A and
B) and a single peak in ESI-MS (data not shown). The purified
enzymes were assayed for SHMT activity (21, 22) and the
specific activity of 1.2  0.2 and 1.8  0.3 units/mg was ob-
served for the SHM1 and SHM2, respectively. The 280/425
absorbance ratio was 4.78 and 3.43 for the purified recombi-
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nant SHM1 and SHM2, respectively, which is within the limits
of the values reported for SHMT from various sources (24).
Molecular Weight and Subunit Structure
The molecular masses of the purified recombinant SHM1
and SHM2 were determined under non-dissociating conditions
as described by Andrews (25) using the data of gel filtration
experiments. Gel filtration of SHM1 and SHM2 on a Superdex
S-200 column, calibrated with the various molecular weight
standards, showed a single peak although with a slight differ-
ence in retention volume of 14.55 and 14.7 ml, respectively, for
the two enzymes (Fig. 1C). When the elution volumes of the
marker proteins were plotted as a function of log of molecular
masses, the molecular masses of 91.2 and 87.1 kDa were ob-
tained for SHM1 and SHM2, respectively.
From the primary amino acid sequence, the molecular
masses of 45.03 and 45.52 kDa were obtained for SHM1 and
SHM2, respectively. The subunit masses of purified SHM1 and
SHM2 were determined by SDS-PAGE. A single homogeneous
protein band corresponding to molecular mass of about 45 kDa
was observed for the two proteins (Fig. 1, A and B). The precise
molecular weights of the two recombinant enzymes were ob-
tained by ESI-MS experiments (data not shown). Molecular
masses of 45.0 and 45.5 kDa were observed for SHM1 and
SHM2, respectively, demonstrating that both the recombinant
enzymes have very similar molecular masses.
The results of the studies on subunit masses along with the
size exclusion chromatography as reported above demonstrate
that both SHM1 and SHM2 exist as dimers under physiological
conditions. Furthermore, as both the proteins have similar
molecular masses but significant differences are observed in
their retention volumes (on size exclusion chromatography), it
suggests that significant differences exist in the molecular
dimensions of the two recombinant enzymes with SHM2 hav-
ing a slightly more compact conformation (higher retention
volume) than the SHM1 under physiological conditions.
Content of PLP
The SHMT is a PLP-dependent enzyme in which the PLP is
covalently attached to the enzyme, bound as an aldimine to
Lys-299 that is conserved in SHMT from various sources (12–
14). Visible CD studies on SHMT have shown that the visible
CD signal is different between the holo- and the apo- or un-
folded enzyme. The holoenzyme has a unique peak at 425 nm
because of the bound PLP, which disappears on unfolding of the
enzyme or on removal of PLP from the enzyme, i.e. on stabili-
zation of apoenzyme (16). The visible CD spectra of SHM1 and
SHM2 are shown in Fig. 2A. For both the recombinant proteins
a visible CD spectra centered at about 430 nm, showing the
presence of the enzyme-bound PLP, was observed. However, at
a similar enzyme concentration the visible CD signal for SHM2
was about 8 times greater than that observed for the SHM1
indicating that it probably has a higher content of PLP as
compared with SHM1. To confirm this, the amount of PLP
FIG. 1. SDS-PAGE analysis of E. coli
lysate overexpressing SHM1 (panel A)
and SHM2 (panel B) and the purified pro-
teins. In panel A, lanes 1–4, represent
molecular weight markers, uninduced
culture, induced culture, and purified pro-
tein, respectively. In panel B, lanes 1–3,
represent molecular weight markers, un-
induced culture, and purified protein, re-
spectively. Panel C represents size-exclu-
sion chromatographic profiles for SHM1
(solid line) and SHM2 (dashed line) on the
Superdex 200HR column at pH 7.6 and
25 °C. The experimental details are given
under ‘‘Experimental Procedures.’’
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FIG. 2. CD and fluorescence properties of SHM1 and SHM2 at pH 7.6 and 25 °C. A, visible CD spectra of native recombinant proteins. B,
far-UV CD spectra of native recombinant proteins. C, tryptophan fluorescence emission spectra of native recombinant proteins. In all the figures
the solid lines represent data for SHM1 and the dashed line that for SHM2. Fluorescence emission spectra of native, pH 7.6, and unfolded (in
presence of 8 M urea) PyP-SHM1 (panel D) and PyP-SHM2 (panel E). In both figures, the solid lines represent data for native protein and dashed
lines for unfolded protein.
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bound to the enzyme was determined for both recombinant
enzymes by the method of Urevitch and Kallen (25) after ex-
tensive dialysis of the purified recombinant enzymes against 25
mM potassium phosphate buffer, pH 7.6, 50 mM NaCl, and 1 mM
EDTA. The SHM1 and SHM2were found to contain 1 0.2 and
2.3  0.5 mol of PLP/mol of enzyme, respectively.
The SHMT frommammalian sources are homotetramers and
contain 4 mol of PLP/mol of enzyme (12, 13), whereas the
SHMT from E. coli as well as from other bacterial sources are
dimeric and contain 2 mol of PLP/mol of enzyme (14). All the
SHMTs reported to date including SHM2 (reported in this
paper) contain 2 mol of PLP/mol of enzyme dimer, however,
SHM1 was found to contain only 1 mol of PLP/mol of enzyme
dimer. This is the first report on such a unique stoichiometry of
PLP and enzyme for SHMT.
Comparative Structural and Functional Properties of the
Recombinant SHM1 and SHM2
Secondary Structure—Far-UV CD studies were carried out
on both SHM1 and SHM2 to analyze the differences in the
secondary structure that exist between the two enzymes. For
both SHM1 and SHM2, the far-UV CD spectra characteristic of
a protein having both -helix and -sheet secondary structure
was observed (Fig. 2B). However, for similar molar concentra-
tions of enzyme, a significantly higher ellipticity was observed
for SHM2 over the whole far-UV region (Fig. 2B). This obser-
vation suggests that SHM2 have a significantly higher second-
ary structure as compared with SHM1. Despite having similar
subunit molecular mass as SHM1, the SHM2 was found to have
a more compact conformation. One possible reason for this may
FIG. 3. Alignment of the amino acid sequence of SHMT from various sources. The alignment was done with the software CLUSTALW.
The arrow denotes the site of the octapeptide having five threonine residues, which is conserved in all SHMT except SHM1 and SHM2. The light
shaded letters indicate the amino acids involved in binding of enzyme to the PLP.
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FIG. 4. Comparative analysis of
functional properties of SHM1 and
SHM2 at pH 7 and 25 °C. Effect of L-
cysteine on the absorption spectra of
SHM1 (panel A) and SHM2 (panel B). In
both A and B the solid curves represent
absorption spectrum of enzyme (5 M) in
0.01 M potassium phosphate, pH 7.6, and
the dashed curve represents absorption
spectra of enzyme after addition of 100
mM L-cysteine and incubation for 20 min.
C, pH-induced changes in enzyme activity
of SHM1 (triangles) and SHM2 (circles).
The experimental details are given under
‘‘Experimental Procedures.’’
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be the presence of a significantly higher secondary structure in
SHM2, which would result in stabilization of a compact
conformation.
Tryptophan Fluorescence—According to the primary amino
acid sequence, SHM1 has two tryptophan molecules at posi-
tions 172 and 421, whereas SHM2 has a single tryptophan at
position 175. The fluorescence spectra of SHM1 and SHM2 are
shown in Fig. 2C. For both the enzymes the emission wave-
length maxima for the tryptophan fluorescence was observed at
about 339 nm, however, there were significant differences in
fluorescence intensities of the two enzymes because of the
difference in number of tryptophan moieties present in them.
The buried tryptophan residues in folded protein show fluores-
cence emission maxima at 330–335 nm, whereas on unfolding
of protein the tryptophan fluorescence emission maxima shifts
to about 350 nm (27). Hence, both in SHM1 and SHM2 the
tryptophan molecule(s) is not completely buried but partially
exposed to the solvent.
Fluorescence Resonance Energy Transfer—For eSHMT it has
been demonstrated that reduction of the PLP aldimine bond
results in absorbance maxima at 355 nm that overlaps the
emission spectrum of tryptophan. Hence, the PyP can be used
as an energy acceptor of tryptophan fluorescence. For native
eSHMT FRET is observed that abolishes on unfolding of en-
zyme (20). Fig. 2, D and E, summarizes the results of FRET
experiments on SHM1 and SHM2. For both the SHM1 and
SHM2 in the native conformation two emission maxima, one
around 339 nm (tryptophan fluorescence) and the other at 385
nm (PyP emission resulting from FRET) were observed. How-
ever, on unfolding of enzymes by incubation in 8 M urea only
single emission maximum at 352 nm was observed. These
observations demonstrate that for SHM1 and SHM2 in the
native conformation there is FRET between tryptophan resi-
dues and the bound PLP suggesting that the tryptophan resi-
due(s) is located less than 5 Å from PyP in the native confor-
mation of these two enzymes and on denaturation of the
enzymes these two moieties move apart resulting in the loss of
FRET.
Functional Properties—All the forms of SHMT for which a
primary sequence is known contain the eight-residue conserved
sequence, VTTTTHK(Pyr)T, near the active-site lysyl residue
(Lys-229 as in eSHMT) that forms the internal aldimine with
pyridoxal phosphate. The active site octa-peptide from SHMT
is unusual in the sense that it has five threonine residues
conserved in all the reported primary sequence of SHMTs (Fig.
3). Mutation studies have demonstrated that Thr-226 plays an
important role in converting the gem-diamine complex to ex-
ternal aldimine complex. A T226A mutant of eSHMT has been
shown to distinguish between substrates and substrate analogs
in formation of the gem-diamine complex (28). The primary
sequence of SHM1 and SHM2 show significant changes in the
conserved threonine sequence (Fig. 3). In SHM1, the Thr-225
(corresponding to Thr-227 of eSHMT) and Thr-222 (correspond-
ing to Thr-224 of eSHMT) are replaced with valine and serine,
respectively. In SHM2 the Thr-226 (corresponding to Thr-225
of eSHMT) is replaced by serine (Fig. 3). These alterations may
lead to significant changes in substrate binding and complex
formation in these enzymes.
It has been reported that D-alanine reacts with SHMT to
undergo a slow half-transamination reaction resulting in the
formation of apoenzyme, pyridoxamine-P, and pyruvate (29).
Experimentally this reaction is detected by a decrease of the
absorption at 410 nm (present in native SHMT) and appear-
ance of an absorption peak at 327 nm on incubation of SHMT
with D-alanine (29). Incubation of approximately 100 mM D-
alanine did not result in any change in absorption intensity at
410 nm for the native SHM1 or SHM2 (data not shown), which
demonstrates that D-alanine does not react with either SHM1
or SHM2.
L-Cysteine has been shown to be an agent, which can be used
to resolve the SHMT at neutral pH probably by combining with
the enzyme-bound PLP and forming a more stable thiazolidine
complex (30). Experimentally this reaction is detected by de-
crease of absorption at 410 nm (present in the native SHMT)
and appearance of an absorption peak at 330 nm on incubation
of SHMT with L-cysteine. Fig. 4, A and B, shows the absorption
spectra of SHM1 and SHM2 and on incubation with L-cysteine.
Incubation of SHM1 and SHM2 with 100 mM L-cysteine re-
sulted in absolute loss of absorption intensity at 410 nm for
both the recombinant enzymes and appearance of an absorp-
tion peak at 330 nm demonstrating that the enzyme-bound
PLP in SHM1 or SHM2 has been removed by L-cysteine.
The pH dependence of the enzymatic activity of SHM1 and
SHM2 was studied and is summarized in Fig. 4C. For both
enzymes, bell-shaped curves centered at about pH 7.8 were
observed. Furthermore, a complete loss of activity was ob-
served at pH below 4.0 and above 10.0. These observations
demonstrate that both SHM1 and SHM2 have similar pH op-
tima for the enzymatic activity.
FIG. 5. Thermal denaturation of na-
tive recombinant enzymes measured
by loss of CD ellipticity at 222 nm. A
linear extrapolation of baselines in pre-
and post-transitional regions was used to
determine the fraction-unfolded protein
within the transition region by assuming
a two-state mechanism of unfolding. The
solid and dashed lines represent data for
SHM1 and SHM2, respectively. The ther-
mal transition was found to be irreversi-
ble and the precipitation of the recombi-
nant enzymes was observed at about
90 °C irrespective of the buffer used.
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Comparative Denaturation Studies on SHM1 and SHM2
Thermal Denaturation—The thermal unfolding of SHM1
and SHM2 were characterized by monitoring the loss of sec-
ondary structure of enzymes with temperature. Fig. 5 summa-
rizes the changes in CD ellipticity at 222 nm for SHM1 and
SHM2 at increasing temperatures. For both enzymes, a single
irreversible sigmoidal transition was observed suggesting a
cooperative thermal unfolding of native enzyme dimer to un-
folded monomer. Furthermore, for both enzymes the transition
was observed in the temperature region 40–80 °C, however, it
was centered at about 60 and 69.4 °C for SHM1 and SHM2,
respectively. As a difference of about 9 °C in the Tm was ob-
served for the two enzymes it demonstrates that SHM2 has
higher thermal stability than SHM1, which is probably because
of the presence of a more compact native conformation having
higher secondary structure than SHM1.
pH-induced Denaturation—Far-UV and visible CD studies
on SHM1 and SHM2 at increasing pH were performed to study
the pH-induced alterations in the secondary structure and the
PLP-binding site of the two enzymes. In the pH range between
4 and 5, aggregation was observed for both enzymes (data not
shown). However, at about pH 3.0, monomers of both enzymes
were found to be stabilized (glutaraldehyde cross-linking ex-
periments summarized in Fig. 6, A and B, inset). In contrast, in
the alkaline pH range significant differences in the structural
properties of the two enzymes were observed. Because of this
reason structural changes in the recombinant enzymes in the
alkaline pH range are being discussed in detail.
Fig. 7A summarizes the effect of increasing pH, between pH
6 and 11, on the CD ellipticity at 222 nm for SHM1 and SHM2.
For SHM2, a sigmoidal transition was observed between pH 8
and 10 with about 50% loss of the CD ellipticity at 222 nm
associated with this transition. In contrast, for SHM1 no sig-
nificant alteration in CD ellipticity at 222 nm was observed
between pH 6 and 11. These results demonstrate that second-
ary structure of native SHM1 is not significantly affected by
FIG. 6. pH-induced alterations in
molecular dimension and subunit
configuration of SHM1 and SHM2. A,
size-exclusion chromatographic profiles
for SHM1 on Superdex 200HR column at
increasing pH. The curves 1–3 represent
profiles for pH 7.6-, 9-, and 10.5-treated
SHM1 protein samples, respectively. B,
size-exclusion chromatographic profiles
for SHM1 on the Superdex 200HR column
at increasing pH. Curves 1 and 2 repre-
sent profiles for pH 7.5- and 9-treated
SHM2 protein samples. For these studies
citrate/glycine/Hepes buffer (10 mM each)
was used and the desired pH was main-
tained with 1 N NaOH or HCl. The col-
umns were run at the pH at which the
protein samples were incubated. In both
figures the insets show SDS-PAGE pro-
files of glutaraldehyde cross-linked pH
3–10.5-treated protein samples. Lanes 1
and 2 represent molecular weight mark-
ers, and uncross-linked native protein, re-
spectively and lanes 3–5 represent cross-
linked samples of pH 3-, 7.5-, and 10-
treated protein, respectively.
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enhancing the pH to 11.0, however, for SHM2 a significant
denaturation occurs under similar conditions.
Fig. 7B summarizes the changes in visible CD signal of
SHM1 and SHM2 between pH 6 and 11. For both enzymes, a
sigmoidal transition for loss of CD signal in the visible region
was observed in the alkaline pH region. However, for SHM2
the transition was observed between pH 6.5 and 11 centered at
pH 8.0, whereas for SHM1 it was between pH 8 and 11 centered
at about pH 9.25. These results demonstrate that compared
with SHM2, the SHM1 shows higher stability against alkaline
denaturation. Furthermore, for both SHM1 and SHM2 a com-
plete loss of visible CD signal was observed at about pH 10 and
above suggesting that at high pH the enzyme-bound PLP mol-
ecule gets dissociated from both recombinant enzymes result-
ing in stabilization of apoenzymes.
For studying the effect of alkaline pH on the molecular
dimensions of the native SHM1 and SHM2, size exclusion
chromatographic studies were carried out. Fig. 6, A and B,
summarizes the elution profile of SHM1 and SHM2 on the
S-200 Superdex column between pH 7.5 and 10.0. For native
SHM1 at pH 7.5, a single peak with a retention volume of 14.06
ml corresponding to the dimeric species of enzyme was ob-
served. On increase in pH from 7.5 to 10.5, no significant
changes in the retention volumes of the native SHM1 were
observed (Fig. 6A). This suggests that no significant alteration
in the molecular dimension or subunit configuration of SHM1
occurs on enhancement of pH in alkaline region. This was
confirmed by the glutaraldehyde cross-linking studies where a
single protein band corresponding to that of the dimer of the
enzyme was observed between pH 7.5 and 10.5 (Fig. 6A, inset).
In contrast for SHM2, on increase in pH from 7.5 to 9 an
enhancement in the retention volume from 14.13 to 15.2 ml
was observed (Fig. 6B). The enhancement in the retention
volume for pH 9-treated SHM2 compared with the native en-
zyme is indicative of significantly reduced hydrodynamic radii
for the stabilized enzyme intermediate under these conditions.
On comparing the elution volume of pH 9.0-treated SHM2 with
the molecular mass obtained for marker proteins in the size
FIG. 7. A, pH-induced changes in sec-
ondary structure of SHM1 (triangles) and
SHM2 (circles) as monitored by following
the changes in ellipticity at 222 nm ob-
tained from far-UV CD curves at increas-
ing pH. B, pH-induced changes to en-
zyme-bound PLP of SHM1 (triangles) and
SHM2 (circles) as monitored by following
the changes in ellipticity at 425 nm ob-
tained from visible CD spectra at increas-
ing pH.
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exclusion chromatography (with citrate/glycine/Hepes buffer),
a molecular mass of about 45 kDa was obtained. As the SHM2
monomer has a molecular mass of about 45 kDa (Fig. 1), these
observations indicate that alkaline treatment of SHM2 proba-
bly leads to dissociation of native dimer of enzyme resulting in
stabilization of the enzyme monomer. This possibility was con-
firmed by the glutaraldehyde cross-linking studies where a
single protein band corresponding to monomer of enzyme was
observed on SDS-PAGE for pH 9-treated SHM2 (Fig. 6B, inset).
Urea-induced Denaturation—The urea-induced denatur-
ation of SHM1 and SHM2 were studied by monitoring the
changes in the secondary structure, the tertiary structure, and
the enzyme-bound PLP of the recombinant proteins at increas-
ing urea concentrations. Fig. 8A summarizes the changes in the
FIG. 8. A, urea-induced changes in secondary structure of SHM1 (triangles) and SHM2 (circles) as monitored by following the changes in
ellipticity at 222 nm obtained from far-UV CD curves at increasing concentrations of urea. B, changes in the wavelength of maximum fluorescence
emission of tryptophans of SHM1 (triangles) and SHM2 (circles) versus urea concentration. Urea-induced changes of enzyme-bound PLP of SHM1
(triangles) and SHM2 (circles) as monitored by following the changes in ellipticity at 425 nm obtained from visible CD spectra at increasing the
concentrations of urea. Panels D and E show SDS-PAGE profiles of glutaraldehyde cross-linked urea-treated SHM1 and SHM2, respectively. In
both the figures, lanes 1 and 2 represent molecular weight markers and uncross-linked native protein, respectively, and lanes 3–6 represent
cross-linked samples of 0, 0.8, 1.6, and 2 M urea-treated protein samples, respectively.
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far-UV CD signal of SHM1 and SHM2 on treatment with
increasing concentrations of urea. For both enzymes, an expo-
nential decrease in CD ellipticity at 222 nm between 0 and 6 M
urea and complete loss of CD signal above 6.5 M urea were
observed. These observations suggest that both SHM1 and
SHM2 undergo a continuous loss of secondary structure on
treatment with increasing concentration of urea.
The urea-induced alterations in tertiary structure of recom-
binant proteins SHM1 and SHM2 was studied by monitoring
the changes in the tryptophan fluorescence emission wave-
length maxima at increasing concentrations of urea and are
summarized in Fig. 8B. An exponential increase in tryptophan
fluorescence emission wavelength maxima from 339 to 356 nm
for both the SHM1 and SHM2 were observed with increasing
urea concentrations between 0 and 5 M urea. These observa-
tions suggest that treatment of enzyme with increasing con-
centrations of urea lead to movement of partially buried tryp-
tophan molecules present in the native enzyme toward the
solvent (27). Such a situation can arise only when the enzyme
molecule undergoes unfolding on treatment with urea. The
FIG. 9. A, GdmCl-induced changes in secondary structure of SHM1 (triangles) and SHM2 (circles) as monitored by following the changes in
ellipticity at 222 nm obtained from far-UV CD curves at increasing concentrations of GdmCl. B, GdmCl-induced changes of enzyme-bound PLP of
SHM1 (triangles) and SHM2 (circles) as monitored by following the changes in ellipticity at 425 nm obtained from visible CD spectra at increasing
concentrations of GdmCl. C, changes in the wavelength of maximum fluorescence emission of tryptophans of SHM1 (triangles) and SHM2 (circles)
versus GdmCl concentration. The inset shows the changes between 0 and 2 M GdmCl. Panels D and E show SDS-PAGE profiles of glutaraldehyde
cross-linked urea-treated SHM1 and SHM2, respectively. In both figures, lanes 1 and 2 represent molecular weight markers and uncross-linked
native protein, respectively, and lanes 3–5 represent cross-linked samples of 0, 0.2, and 2 M GdmCl-treated protein samples, respectively.
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far-UV CD and tryptophan fluorescence results presented
above collectively demonstrate that during the urea-induced
denaturation a simultaneous unfolding of both the secondary
and tertiary structures occurs in both SHM1 and SHM2.
The urea-induced changes in the enzyme-bound PLP of
SHM1 and SHM2was studied by monitoring the changes in the
visible CD signal of the enzymes at increasing urea concentra-
tion. A sharp decrease in CD signal at 425 nm was observed
between 0–1 and 0–1.2 M urea for SHM1 and SHM2, respec-
tively. Above 1.25 M urea concentration, a complete loss of
visible CD signal was observed for both recombinant enzymes
suggesting that for both SHM1 and SHM2 the enzyme-bound
PLP gets dissociated from the enzyme on treatment with about
1.25 M urea. However, at about 1.25 M urea only about 40% loss
of CD ellipticity at 222 nm and partial exposure of tryptophan
residues of enzyme to solvent was observed for the two en-
zymes. This indicates a possibility of stabilization of a partially
unfolded apo-intermediate of SHM1 and SHM2 on treatment
with low concentrations of urea.
The effect of urea on the subunit configuration of SHM1 and
SHM2 was studied by carrying out glutaraldehyde cross-link-
ing studies. Fig. 8, C and D, summarizes the results of the
glutaraldehyde cross-linking results of the native and 1.6 M
urea-treated SHM1 and SHM2. For 1.6 M urea-treated SHM2,
a single protein band corresponding to monomer of enzyme was
observed, whereas for SHM1 two protein bands corresponding
to monomer and dimer, respectively, were observed. These
observations in conjunction with the results of CD and trypto-
phan fluorescence studies demonstrate that treatment of
SHM1 and SHM2 with low urea concentrations leads to disso-
ciation of native dimer of these enzymes resulting in stabiliza-
tion of an apomonomer.
Guanidinium Chloride-induced Denaturation
The GdmCl-induced denaturation of SHM1 and SHM2 was
studied by monitoring the alterations in far-UV and visible CD
and tryptophan fluorescence profiles of the two enzymes at
increasing GdmCl concentrations. Fig. 9, A and B, summarizes
the far-UV and visible CD changes in SHM1 and SHM2 be-
tween 0 and 5 M GdmCl. For both enzymes, a sharp exponential
decrease in CD ellipticity at 425 nm with increasing GdmCl
concentrations were observed between 0 and 1.25 M GdmCl.
Above 1.5 M GdmCl a complete loss of visible CD signal for
SHM1 and SHM2 were observed suggesting dissociation of the
enzyme-bound PLP under these conditions. However, for CD
ellipticity at 222 nm an initial sharp loss of about 60% of signal
was observed between 0 and 0.5 M GdmCl followed by a gradual
loss of ellipticity between 0.75 and 4 M GdmCl. As the GdmCl
concentration at which the dissociation of enzyme-bound PLP
was found to occur only about 60% loss of secondary structure
of enzyme was observed, these observations indicate a possi-
bility of stabilization of a partially unfolded intermediate dur-
ing GdmCl denaturation of both enzymes (31).
The stabilization of a partially unfolded intermediate of
SHM1 and SHM2 during GdmCl-induced unfolding of enzymes
was further supported by the tryptophan fluorescence studies.
Fig. 9C shows the changes in tryptophan fluorescence emission
wavelength maxima on treatment of SHM1 and SHM2 in the
presence of increasing concentrations of GdmCl. For both
SHM1 and SHM2, two distinct transitions were observed be-
tween GdmCl concentrations of 0 and 6 M. For SHM1 the two
transitions were in the GdmCl concentration ranges 0–1.5 and
1.5–6 M, whereas for SHM2 they were in the GdmCl concen-
tration ranges 0–1 and 1.1–7 M. At GdmCl concentration about
5 M and above the tryptophan fluorescence emission wave-
length maxima of about 354 nm was observed suggesting com-
plete unfolding of enzymes under these conditions (27).
The subunit configuration of the GdmCl-stabilized interme-
diate of SHM1 and SHM2 was characterized by glutaraldehyde
cross-linking experiments and are summarized in Fig. 9, D and
E. For 0.2 M GdmCl-treated SHM1 and SHM2, two protein
bands corresponding to dimer and monomer, respectively, of
the recombinant enzymes were observed. However, for SHM1
the population corresponding to the monomer of the enzyme
was significantly higher compared with that for the dimer (Fig.
9D). In contrast for SHM2 an almost equal population of the
monomer and dimer was observed (Fig. 9E). The above re-
ported observations collectively demonstrate that treatment of
SHM1 and SHM2 with low concentrations of GdmCl lead to
dissociation of the native dimer of enzymes along with dissoci-
ation of enzyme bound PLP, resulting in stabilization of
apomonomer of enzymes.
The results presented in this paper demonstrate that
M. tuberculosis contains two SHMTs, which despite having
about 66% sequence homology have significantly different
structural and stability properties. The most significant struc-
tural difference between SHM1 and SHMTs from various other
sources including SHM2 is the presence of 1 mol of PLP/
enzyme dimer in SHM1 as compared with 2 mol of PLP/enzyme
dimer for all other reported SHMTs. Such a change in the
stoichiometry of PLP and enzyme in SHMTs would have sig-
nificant consequences in the structure and stability of SHM1 as
PLP has been shown to play a significant role in functional
activity and stability of SHMTs (15). Besides this, the SHM1
was found to have a lesser secondary structure and less com-
pact conformation than the SHM2. Regarding the stability
differences between the SHM1 and SHM2, it was observed that
the SHM2 was more stable than SHM1 against thermal dena-
turation. However, SHM1 showed higher stability than SHM2
against alkaline denaturation.
Comparative analysis of mammalian SHMTs (12–14) as re-
ported in literature and the M. tuberculosis SHMTs (both the
SHM1 and SHM2) reported in this paper suggest that signifi-
cant differences exist in their structural and functional prop-
erties between these enzymes. For example, the mammalian
SHMTs are tetramers, whereas theM. tuberculosis SHMTs are
dimers. The mammalian SHMT contains the eight-residue con-
served sequence VTTTTHK(Pyr)T near the active site lysyl
residue (Lys-229 as in eSHMT) that forms the internal aldi-
mine with pyridoxal phosphate. However, the M. tuberculosis
SHMTs show significant changes in the conserved threonine
sequence in the octapeptide (Fig. 3). These unique features of
Mycobacterium SHMTs compared with the mammalian
SHMTs can be exploited for designing drugs against
M. tuberculosis.
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